Neurocrine Bio. (NBIX) PT Raised to $125 at RBC Capital
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $138.40 -0.39%
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $125.00 (from $121.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- Infosys Ltd. (INFO:IN) (INFY) PT Lowered to INR1,030 at Citi
- Nutex Health (NUTX) PT Raised to $306 at Freedom Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
